
US-based infant nutrition company LactaLogics announced the completion of its packaging research and development phase, a partnership project with packaging company Scholle IPN.
Premature babies in hospital neonatal units are extremely susceptible to illness and infection. Accordingly Companies like LactaLogics have to meet high standards when it comes to packaging. For example, when it comes to the packaging and transport of breast milk-based products.
Protect products from contamination and environmental influences
„In our discussions with neonatologists, nurses in the neonatal intensive care unit and breastfeeding counsellors, we identified key problems in the nutrition of premature babies. Even with strict controls, a human-controlled process is prone to errors. The impact can be as small as wasting milk or as devastating as losing a patient,“ explains Chelly Snow, co-founder and COO. „Our partnership with Scholle IPN gives hospitals access to aseptic packaging technology. Human milk no longer needs to be refrigerated and mixing in the open air is minimised, revolutionising the way human milk is administered.“
„Our aseptic packaging, especially for pharmaceuticals, Protect sensitive products from contamination and external environmental influences, which is crucial in the nutrition of premature babies,“ says Andrew Lively, Business Development Manager at Plaice IPN. „The Possibility to combine this with storage stability and controlled, precise dosing, We are delighted and look forward to the positive impact our packaging will have on the lives of premature babies.“
Source: LactaLogics
Further news from the pharma sector


Dioxycle and L'Oréal cooperate

Solutions for safe and sustainable metal packaging

Packaging design as the key to brand communication

Small cosmetics packaging makes sorting more difficult



